Ginkgo Bioworks Holdings Q3 EPS $(1.08) Beats $(2.71) Estimate, Sales $89.05M Beat $45.00M Estimate
Ginkgo Bioworks Holdings Q3 EPS $(1.08) Beats $(2.71) Estimate, Sales $89.05M Beat $45.00M Estimate
Ginkgo Bioworks控股公司Q3每股收益爲$(1.08)，超過了$(2.71)的預期，銷售額爲8905萬元，超過了4500萬元的預期。
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.08) per share which beat the analyst consensus estimate of $(2.71) by 60.15 percent. This is a 82.61 percent increase over losses of $(6.21) per share from the same period last year. The company reported quarterly sales of $89.05 million which beat the analyst consensus estimate of $45.00 million by 97.88 percent. This is a 60.65 percent increase over sales of $55.43 million the same period last year.
Ginkgo Bioworks Holdings（紐交所: DNA）報告每股虧損1.08美元，超過分析師共識預期的2.71美元，增幅達60.15%。這比去年同期每股虧損6.21美元增加了82.61%。該公司報告季度銷售額達到8905萬美元，超過分析師共識預期的4500萬美元，增幅達97.88%。這比去年同期銷售額5543萬美元增加了60.65%。
資訊熱榜
更新時間